Guobang Pharma Ltd. News

Guobang Pharmaceutical (605507): From scale to growth

zheshangNov 29 15:57

Guobang Pharmaceutical (605507): Q3 revenue reached a record high, and exchange gains and losses affected profit levels in the short term

the pacific securitiesOct 22 07:36

Guobang Pharmaceutical (605507): The pharmaceutical sector is growing steadily, and the flexibility of the health insurance business is considerable

tianfeng SecuritiesOct 14 16:26

Guobang Pharmaceutical (605507): APIs and intermediates work together to wait for the steady recovery of the animal insurance business

Sep 3 18:26

Guobang Pharmaceutical (605507) 2024 Semi-Annual Report Review: Profit Performance Exceeds Expectations, Efficient Development of Featured APIs

Sep 1 00:00

Guobang Pharmaceutical (605507): Q2 results slightly exceeded market expectations, and revenue and profit resumed rapid growth

Aug 30 13:16

Guobang Pharmaceutical (605507): The pharmaceutical business is picking up, and the flexibility of the animal insurance business can be expected

Aug 27 00:00

Guobang Pharmaceutical (605507): Repurchase shares to launch employee stock ownership plan, prices of major products have bottomed out

Jul 27 00:00

Guobang Pharmaceutical (605507): Active repurchases show confidence in long-term development

May 17 13:06

Guobang Pharmaceutical (605507): Competition in the mobile insurance sector is intensifying and profitability is expected to gradually improve

Oct 20, 2023 00:00

Guobang Pharmaceutical (605507): Veterinary drug prices are expected to bottom out, and the company's performance is expected to gradually improve

Oct 20, 2023 00:00

Guobang Pharmaceutical (605507): Sales volume of core varieties is growing steadily, and the leading position of APIs continues to be stable

西部證券Aug 3, 2023 12:37

Guobang Pharmaceutical (605507): Under pressure from the pharmaceutical intermediates and active pharmaceutical APIs business, net profit of the return mother decreased 28% year-on-year in the first half of the year

國信證券Aug 2, 2023 12:42

Guobang Pharmaceutical (605507): Cost advantages help the company grow against adversity

西南證券Jul 29, 2023 00:00

Guobang Pharmaceutical (605507) 2022 Report and 2023 Quarterly Report Reviews: Net profit of the 22-year return mother +30% compared to the previous year, and the gross margin of the 23Q1 mobile insurance sector bucked the trend

國信證券Apr 19, 2023 10:03

Guobang Pharmaceutical (605507): The pharmaceutical sector is growing steadily and the insurance business is rapidly expanding

信達證券Apr 17, 2023 16:22

Guobang Pharmaceutical (605507) 2022 Report Review: Pharmaceutical and Animal Insurance Sectors Expand, and the Competitiveness of the Pharmaceutical Manufacturing Industry Chain Continues to Strengthen

西部證券Apr 17, 2023 00:00

Guobang Pharmaceutical (605507): Product Quality Matrix, Rich Categories, Expanding Performance

西南證券Apr 16, 2023 00:00

Guobang Pharmaceutical (605507) In-depth Report: The Performance of Leading Veterinary Chemical Companies Is Growing Rapidly

西部證券Dec 28, 2022 00:00

Guobang Pharmaceutical (605507) Company's First Coverage Report: Pharmaceutical and Animal Insurance Two-wheel Drive Entered a Period of Rapid Development

信達證券Dec 26, 2022 00:00